Italian-style coffee may halve prostate cancer risk: study

Image
Press Trust of India London
Last Updated : Apr 27 2017 | 3:28 PM IST
Drinking three or more cups of caffeinated coffee a day may reduce the risk of prostate cancer by more than 50 per cent, a new Italian study claims.
The study sheds light on the role of coffee prepared the Italian way, and specifically caffeine, in relation to prostate cancer.
Italians prepare their coffee rigorously, under high pressure, with very high water temperature and without filters.
About 7,000 men who participated in the study were observed for four years on average.
"By analysing their coffee consumption habits and comparing them with prostate cancer cases occurring over time, we saw a net reduction of risk, 53 per cent, in those who drank more than three cups a day," said George Pounis, researcher at IRCCS Neuromed - Mediterranean Neurological Institute in Italy.
The researchers confirmed the results by testing the action of coffee extracts on prostate cancer cells in laboratory studies.
They tested both caffeinated and decaffeinated varieties. Only caffeinated coffee extracts significantly reduced cancer cell proliferation and metastasization. This effect was not observed with decaf, researchers wrote in the study published in the International Journal of Cancer.
"The observations on cancer cells allow us to say that the beneficial effect observed among the 7,000 participants is most likely due to caffeine, rather than to the many other substances contained in coffee," said Maria Benedetta Donati, head of the Laboratory of Translational Medicine in Italy.
"We should keep in mind that the study is conducted on a central Italian population. They prepare coffee rigorously, the Italian way: high pressure, very high water temperature and with no filters," said Licia Iacoviello, head of the Molecular and Nutritional Epidemiology Laboratory at IRCCS Neuromed.
"This method, different from those followed in other areas of the world, could lead to a higher concentration of bioactive substances," said Iacoviello.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 27 2017 | 3:28 PM IST

Next Story